A Phase I Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2019
Price : $35 *
At a glance
- Drugs Cisplatin (Primary) ; Mitomycin (Primary) ; Paclitaxel (Primary) ; Dexamethasone; Diphenhydramine; Famotidine
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 04 Jun 2019 Results (n=27; as of Nov 2018) presented at the 55th Annual Meeting of the American Society of Clinical Oncology.
- 05 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Nov 2017 New trial record